Cargando…
Ulcerative Colitis: Current and Emerging Treatment Strategies
Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the cur...
Autores principales: | Kayal, Maia, Shah, Shailja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019865/ https://www.ncbi.nlm.nih.gov/pubmed/31905945 http://dx.doi.org/10.3390/jcm9010094 |
Ejemplares similares
-
Current and Emerging Biologics for Ulcerative Colitis
por: Park, Sung Chul, et al.
Publicado: (2015) -
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022) -
Sex-based differences in inflammatory bowel diseases: a review
por: Rustgi, Sheila D., et al.
Publicado: (2020) -
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
por: Gledhill, Tamsin, et al.
Publicado: (2013) -
Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley, Gia M, et al.
Publicado: (2012)